These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2879362)

  • 1. [Immunoregulatory lymphocyte subpopulations in patients with dilated and hypertrophic cardiomyopathies].
    Chumburidze VB; Iurenev AP; Tabazari DZ; Dzidziguri LM; Krukovskaia ZV
    Ter Arkh; 1986; 58(10):59-62. PubMed ID: 2879362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of immunological studies in various forms of cardiomyopathy].
    Iurenev AP; Chumburidze VB; Polianskaia IS; Iazdovskiĭ VV; Krukovskaia ZV
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(2):101-6. PubMed ID: 3501296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immune response in patients with dilated cardiomyopathy.
    Dabrowski M; Grzelak I; Ruzyłło V; Lukomska B; Sadowska-Szablisty D; Olszewski WL
    Cor Vasa; 1989; 31(6):476-84. PubMed ID: 2637101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics of immunoregulatory lymphocyte subpopulations in patients with congestive cardiomyopathy and nonrheumatic myocarditis studied by monoclonal antibodies].
    Kipshidze NN; Chumburidze VB; Dzidziguri LM; Detashidze MN
    Ter Arkh; 1984; 56(10):56-8. PubMed ID: 6151750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic characterization of infiltrates in dilated cardiomyopathy - diagnostic significance of T-lymphocytes and macrophages in inflammatory cardiomyopathy.
    Noutsias M; Pauschinger M; Schultheiss H; K hl U
    Med Sci Monit; 2002 Jul; 8(7):CR478-87. PubMed ID: 12118194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quantitative and functional evaluation of immunoregulating cells and natural killers in patients with aplastic anemia].
    Pogorel'skaia EP; Skriabina EG; Aĭtmatova GS; Saidov MZ; Svirezheva MN
    Ter Arkh; 1985; 57(7):71-4. PubMed ID: 3901381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibody-dependent and natural cellular cytotoxicity in patients with dilated cardiomyopathy].
    Bakhov NI; Aleksandrova LZ; Osipov SG; Naumov VG; Rudnev VI
    Ter Arkh; 1986; 58(10):62-7. PubMed ID: 3798351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peripheral T-lymphocyte subpopulations in primary and alcoholic dilated cardiomyopathy].
    Sachs RN; Hatron PY; Saizy C; Lanfranchi J
    Ann Med Interne (Paris); 1985; 136(3):229-32. PubMed ID: 3161445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunoregulatory disorders and activation of the immune system in dilated cardiomyopathy].
    Nasonov EL; Aleksandrova LZ; Samsonov MIu; Aleksandrova EN; Gracheva LA
    Ter Arkh; 1988; 60(7):25-30. PubMed ID: 2905541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory dilated cardiomyopathy (DCMI).
    Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
    Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological status and pathology of coxsackie B viral myocarditis and dilated cardiomyopathy.
    Chen SX; Mei SW; Bao SH; Zheng XJ; Chang PL; Yao JS; Yao S; Zhang DQ
    Chin Med J (Engl); 1993 Sep; 106(9):659-64. PubMed ID: 8287699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors.
    Damle NK; Doyle LV; Bradley EC
    J Immunol; 1986 Nov; 137(9):2814-22. PubMed ID: 2944965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
    Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
    J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of immunoregulatory cells and natural killers in the pathogenesis of multiple sclerosis].
    Tunkel' OI; Saidov MZ; Cheredeev AN; Koval'chuk LV; Skriabina EG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(6):880-5. PubMed ID: 6224384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy?
    Tanaka T; Sohmiya K; Kawamura K
    J Mol Cell Cardiol; 1997 Jan; 29(1):121-7. PubMed ID: 9040027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Unclassified cardiomyopathies: subspecies and their transformation].
    Ikeda Y; Kawai S; Okada R; Yamaguchi H
    J Cardiol; 1998 Feb; 31(2):91-7. PubMed ID: 9513036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
    Karlsson FA; Tötterman TH
    Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of natural killer cell cytotoxicity during the graft-versus-host reaction. Relationship between natural killer cell activity, T and B cell activity, and development of histopathological alterations.
    Ghayur T; Seemayer TA; Lapp WS
    Transplantation; 1987 Aug; 44(2):254-60. PubMed ID: 3498241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of lymphocyte subpopulation and subsets in patients with idiopathic cardiomyopathy].
    Sakai H; Iwatani Y; Katayama Y
    Rinsho Byori; 1988 Jun; 36(6):705-9. PubMed ID: 3210320
    [No Abstract]   [Full Text] [Related]  

  • 20. [Regulation of the natural killer activity of lymphocytes from healthy donors and patients with chronic lympholeukemia through the interaction of T- and non-T cells].
    Khonina NA; Shubinskiĭ GZ; Lozovoĭ VP
    Biull Eksp Biol Med; 1987 Mar; 103(3):321-3. PubMed ID: 3493815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.